On January 13, 2023 QT Imaging, Inc., a medical imaging company focused on the development and clinical adoption of novel products for breast cancer imaging ("QT Imaging"), reported participation of John Klock, MD, Chief Executive Officer, in the Third Annual B. Riley Securities Oncology Conference, on January 18th and 19th (Press release, QT Imaging, JAN 13, 2023, View Source [SID1234626228]). The event will feature one-on-one discussions, fireside chats, and presentations regarding cancer treatment, testing, and monitoring modalities with public and private healthcare companies.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live and archived webcast of the presentation will be accessible from the company’s website at View Source The replay of the webcast will be available for 30 days.